ArticleInternational journal of general medicine2025
Development and Validation of a Predictive Nomogram for Postpartum Hemorrhage in Pregnant Women: A Retrospective Study.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postpartum hemorrhage (PPH) remains a major contributor to maternal morbidity and mortality worldwide. Early identification of high-risk women is crucial for implementing targeted interventions. This study aimed to develop and validate a predictive nomogram that integrates key maternal and perinatal risk factors to estimate the risk of PPH. Methods: In this retrospective study, 336 pregnant women who delivered at our hospital from January 2022 to January 2024 were included. PPH was defined as blood loss >500 mL after vaginal delivery or >1000 mL after cesarean section. Independent predictors were identified using forward stepwise multivariable logistic regression and incorporated into a nomogram. Discrimination was evaluated by the area under the receiver operating characteristic curve (AUC) and concordance index (C-index); calibration by the Hosmer-Lemeshow test and calibration curves; clinical utility by decision curve analysis (DCA). Internal validation used 1000 bootstrap resamples. Results: Participants were classified into non-PPH (n = 281) and PPH (n = 55) groups. Independent predictors of PPH included advanced maternal age (≥35 years), uterine atony, various placental abnormalities (previa, abruption, adhesion, and retained placenta), adverse obstetric history, cesarean delivery, higher prenatal weight, instrumental delivery, birth canal tears, multiple gestations, macrosomia, coagulopathy, uterine fibroids, and adverse psychological status (all p < 0.05). The nomogram achieved an AUC of 0.786 (95% CI: 0.695-0.865) and a corrected C-index of 0.796. Calibration was excellent (Hosmer-Lemeshow, p = 0.912), and DCA confirmed its clinical utility. Conclusion: This internally validated nomogram showed strong predictive performance for PPH using routinely collected clinical and psychosocial data. Future studies should conduct external validation and prospective multicenter evaluation to confirm its generalizability and clinical applicability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.